Skip Navigation LinksHome > November 2011 - Volume 19 - Issue 6 > Staphylococcus aureus Bacteremia and Endocarditis: The Role...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e31823b4e96
NFID Clinical Updates

Staphylococcus aureus Bacteremia and Endocarditis: The Role of Device and Lead Extraction

Wilkoff, Bruce L. MD*

Erratum

Erratum

In the article by Wilkoff, appearing in Infectious Diseases in Clinical Practice, Vol. 19, No. 6, pp. 376–381, entitled “Staphylococcus aureus Bacteremia and Endocarditis: The Role of Device and Lead Extraction,” the following commercial support information was inadvertently omitted from the submission: “This activity is supported by an unrestricted educational grant from Cubist Pharmaceuticals.”

Infectious Diseases in Clinical Practice. 21(1):74, January 2013.

Collapse Box

Abstract

Diagnosing infections in patients with implantable devices is challenging. Once the diagnosis is made, managing the infection requires complete device extraction in most of the patients, followed by appropriate antibiotic therapy and reimplantation in patients who meet the appropriate criteria. The use of an algorithm in determining appropriate steps of management results in low relapse rates. Healthcare professionals need to understand the indications for transvenous lead extractions. Specialized equipment, procedures, and techniques are required for the extractions. Among patients for whom lead extractions are indicated, the procedure has proven to be safe; however, patients with device-related endocarditis, especially in the setting of diabetes and renal failure, may have higher mortality rates with these procedures.

© 2011 Lippincott Williams & Wilkins, Inc.

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.